[1]韩冬,王贵佐,李满祥.腺苷酸活化蛋白激酶在肺部疾病中的作用[J].中国药理学通报,2013,(04):460-463.
 HAN Dong,WANG Gui zuo,LI Man xiang.Role of AMPK in pulmonary diseases[J].Chinese Pharmacological Bulletin,2013,(04):460-463.
点击复制

腺苷酸活化蛋白激酶在肺部疾病中的作用()
分享到:

《中国药理学通报》[ISSN:/CN:]

卷:
期数:
2013年04期
页码:
460-463
栏目:
讲座与综述
出版日期:
2013-04-23

文章信息/Info

Title:
Role of AMPK in pulmonary diseases
作者:
韩冬王贵佐李满祥
西安交通大学医学院第二附属医院呼吸病研究室,呼吸内科, 陕西 西安710004
Author(s):
HAN Dong WANG GuizuoLI Manxiang
Institution of Respiratory Medicine, Dept of Respiratory Medicine, the Second Affiliated Hospital, Xi′an Jiaotong University College of Medicine, Xi′an710004, China
关键词:
腺苷酸活化蛋白激酶结构和功能治疗作用肺癌支气管哮喘肺动脉高压
Keywords:
structure and function therapeutic effectlung cancerasthmaPAH
分类号:
R05;R345.57;R563;R9773
文献标志码:
A
摘要:
腺苷酸活化蛋白激酶(AMPactivated protein kinase,AMPK)是一种广泛参与人体内能量代谢活动的蛋白激酶。新近的研究发现,AMPK可调控多种疾病发生、发展过程中的病理环节。近年来,AMPK与肺部疾病的关系愈发受到人们的重视,目前研究认为AMPK对肺癌、支气管哮喘及肺动脉高压等肺部疾病的治疗具有潜在的作用。该文就AMPK的生物学特性及其对多种肺部疾病的潜在治疗作用进展做一综述。
Abstract:
AMPK is an important protein kinase, which controls/regulates the activity of energy metabolism in human body. Recent study has found that AMPK plays a critical role in the pathophysiological process of a variety of diseases. In recent years, the relationship between AMPK and pulmonary diseases has aroused extensive attention. Studies suggest that AMPK has a potential role in the treatment of pulmonary diseases such as lung cancer, asthma, acute lung injury, pulmonary hypertension and cystic fibrosis. This review summarizes the biological characteristics of AMPK and its potential therapeutic effect on such diseases.

参考文献/References:

[1]Kahn B B, Alquier T, Carling D, Hardie D G. AMPactivated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism[J]. Cell Metab, 2005, 1:15-25.
[2]Minokoshi Y, Alquier T, Furukawa N, et al. AMPkinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus[J]. Nature, 2004, 428:569-74.
[3]Viollet B, Andreelli F, Jorgensen S B, et al. Physiological role of AMPactivated protein kinase (AMPK): insights from knockout mouse models[J]. Biochem Soc Trans, 2003, 31:216-9.
[4]Young L H, Li J, Baron S J, Russell R R. AMPactivated protein kinase: A key stress signaling pathway in the heart[J]. Trends Cardiovasc Med, 2005, 15(3):110-8.
[5]Sun W, Lee T S, Zhu M, et al. Statins activate AMPactivated protein kinase in vitro and in vivo[J]. Circulation, 2006, 114(24):2655-62.
[6]Chisholm J W, Hong J, Mills S A, et al. The LXR ligand T0901317 induces severe lipogenesis in the db /db diabetic mouse[J]. J Lipid Res, 2003, 44(10): 2039-48.
[7]Salt I P, Palmer T M. Exploiting the antiinflammatory effects of AMPactivated protein kinase activation[J]. Exp Opin Invest Drugs, 2012, 21(8):115-67.
[8]Suter M, Riek U, Tuerk R, et al. Dissecting the role of 5′AMP for allosteric stimulation, activation, and deactivation of AMPactivated protein kinase[J]. J Biol Chem, 2006, 281(43):32207-16.
[9]Polekhina G, Gupta A, Michell B J, et al. AMPK beta subunit targets metabolic stress sensing to glycogen[J]. Current Biol, 2003, 13:867-71.
[10]Iseli T J, Walter M, van Denderen B J, et al. AMPactivated protein kinase beta subunit tethers alpha and gamma subunits via its Cterminal sequence (186-270) [J]. J Biol Chem, 2005, 280(14):13395-400.
[11]Hardie D G. AMPactivated protein kinasean energy sensor that regulates all aspects of cell function[J]. Genes Devel, 2011, 25:1895-908.
[12]Oakhill J S, Chen Z P, Scott J W, et al. βSubunit myristoylation is the gatekeeper for initiating metabolic stress sensing by AMPactivated protein kinase (AMPK) [J]. Pnatl Acad Sci USA, 2010, 107(45):19237-41.
[13]Xiao B, Heath R, Saiu P, et al. Structural basis for AMP binding to mammalian AMPactivated protein kinase[J]. Nature, 2007, 449(7161):496-500.
[14]Woods A, Johnstone S R, Dickerson K, et al. LKB1 is the upstream kinase in the AMPactivated protein kinase cascade[J]. Current Biol, 2003, 13(22):2004-8.
[15]Xie Z, Dong Y, Zhang J, et al. Identification of the serine 307 of LKB1 as a novel phosphorylation site essential for its nucleocytoplasmic transport and endothelial cell angiogenesis[J]. Mol Cell Biol, 2009, 29(13):3582-96.
[16]Hawley S A, Pan D A, Mustard K J, et al. Calmodulindependent protein kinase kinasebeta is an alternative upstream kinase for AMPactivated protein kinase[J]. Cell Metabolism, 2005, 2(1):9-19.
[17]Ravnskjaer K, Boergesen M, Dalgaard L T, et al. Glucoseinduced repression of PPARalpha gene expression in pancreatic betacells involves PP2A activation and AMPK inactivation[J]. J Mol Endocrinol, 2006, 36(2):289-99.
[18]Qi J, Gong J, Zhao T, et al. Downregulation of AMPactivated protein kinase by Cideamediated ubiquitination and degradation in brown adipose tissue[J]. EMBO J, 2008, 27(11):1537-48.
[19]Ji H, Ramsey M R, Hayes D N, et al. LKB1 modulates lung cancer differentiation and metastasis[J]. Nature, 2007, 448(7155):807-10.
[20]Jin Q, Feng L, Behrens C, et al. Implication of AMPactivated protein kinase and Aktregulated survivin in lung cancer chemopreventive activities of deguelin[J]. Cancer Res, 2007, 67(24):11630-9.
[21]Memmott R M, Mercado J R, Maier C R, et al. Metformin prevents tobacco carcinogeninduced lung tumorigenesis[J]. Cancer Prev Res, 2010, 3(9):1066-76.
[22]Sanli T, Liu C, Rashid A, et al. Lovastatin sensitizes lung cancer cells to ionizing radiation: modulation of molecular pathways of radioresistance and tumor suppression[J]. J Thorac Oncol, 2011, 6(3):439-50.
[23]Narender N, Shailendra G, Ratna P, et al. 5aminoimidazole4carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis[J]. J Immunol, 2005, 175:566-74.
[24]Peairs A, Radjavi A, Davis S, et al. Activation of AMPK inhibits inflammation in MRL/lpr mouse mesangial cells[J]. Clin Exp Immunol, 2009, 156:542-51.
[25]Zhao X, Zmijewski J W, Lorne E, et al. Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury[J]. Am J Physiol Lung Cell Mol Physiol, 2008, 295:L497-504.
[26]Kim T B, Kim S Y, Moon K A, et al. Fiveaminoimidazole4carboxamide1beta4ribofuranoside attenuates poly (I ∶C)induced airway inflammation in a murine model of asthma[J]. Clin Exp Allergy, 2007, 37:1709-19.
[27]Park S J, Lee K S, Kim S R, et al. AMPK activation reduces vascular permeability and airway inflammation by regulating HIF/VEGFA pathway in a murine model of toluene diisocyanateinduced asthma[J]. Inflamm Res, 2012, 61(10):1069-83.
[28]Lloyd C M, Hawrylowicz C M. Regulatory T cells in asthma[J]. Immunity, 2009, 31:438-49.
[29]Asehnoune K, Strassheim D, Mitra S, et al. Involvement of reactive oxygen species in Tolllike receptor 4dependent activation of NFkappa B[J]. J Immunol, 2004, 172: 2522-9.
[30]Abraham E. Neutrophils and acute lung injury[J]. Crit Care Med, 2003, 31: S195-9.
[31]Guo R F, Ward P A. Role of C5a in inflammatory responses[J]. Annu Rev Immunol, 2005, 23: 821-52.
[32]Zhao X, Zmijewski J W, Lorne E, et al. Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury[J]. Am J Physiol Lung Cell Mol Physiol, 2008, 295: L497-504.
[33]Agard C, RolliDerkinderen M, DumasdeLaRoque E, et al. Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension[J]. Br J Pharmacol, 2009, 158:1285-94.
[34]Andersen C U, Markvardsen L H, Hilberg O, et al. Pulmonary apelin levels and effects in rats with hypoxic pulmonary hypertension[J]. Respir Med, 2009, 103(11):1663-71.
[35]Andersen C U, Hilberg O, Mellemkjr S, et al. Apelin and pulmonary hypertension[J]. Pulm Circ, 2011, 1(3):334-46.
[36]Chandra S M,Razavi H,Kim J, et al. Disruption of the apelinAPJ system worsens hypoxiainduced pulmonary hypertension[J]. Arterioscler Thromb Vasc Biol,2011, 31(4):814-20.
[37]Becker M N, Sauer M S, Muhlebach M S,et al. Cytokine secretion by cystic fibrosis airway epithelial cells[J].Am J Respir Crit Care Med,2004, 169:645-53.
[38]Mall M, Grubb B R, Harkema J R,et al. Increased airway epithelial Na+ absorption produces cystic fibrosislike lung disease in mice[J].Nat Med, 2004, 10:487-93.
[39]Myerburg M M,King J D Jr,Oyster N M, et al. AMPK agonists ameliorate sodium and fluid transport and inflammation in cystic fibrosis airway epithelial cells[J]. Am J Respir Cell Mol Biol,2010, 42(6): 676-84.

相似文献/References:

[1]黄靓,王汉群,张弛,等.新型褪黑素受体激动剂Neu-P11激活AMPK减轻心肌细胞缺氧/复氧损伤[J].中国药理学通报,2014,(01):104.
 HUANG Liang,WANG Han-qun,ZHANG Chi,et al.Neu-P11 protects against hypoxia/reoxygenation injury through AMPK activation in H9c2 myocardial cells[J].Chinese Pharmacological Bulletin,2014,(04):104.

备注/Memo

备注/Memo:
收稿日期:2012-11-08,修回日期:2013-01-13 基金项目:国家自然科学基金资助项目(No 81070045) 作者简介:韩冬(1987-),男,博士生,研究方向:肺动脉高压及分子机制,Email:sesury@gmail.com; 李满祥(1966-),男,博士,教授,主任医师,博士生导师,研究方向:肺动脉高压的分子生物学基础及干预、支气管哮喘气道重塑的分子基础及治疗,通讯作者,Tel:02987679464,Email:manxiangli@hotmail.com
更新日期/Last Update: 2013-04-25